TY - JOUR
T1 - The role of Intestinal-Fatty Acid Binding Proteins and Chitinase-3-Like Protein 1 across the spectrum of dysglycemia
AU - Sianipar, Imelda R.
AU - Sestramita, Sestramita
AU - Pradnjaparamita, Tika
AU - Yunir, Em
AU - Harbuwono, Dante S.
AU - Soewondo, Pradana
AU - Tahapary, Dicky L.
N1 - Funding Information:
This work was supported by grant from Universitas Indonesia [Indexed International Publication Grant For Student Final Project (PUTI Q3) 2020 ] and the Ministry of Research and Technology Republic of Indonesia [ PUPTN Dikti NKB-2766/UN2.RST/HKP.05.00.2020 ].
Publisher Copyright:
© 2021 Diabetes India
PY - 2022/1
Y1 - 2022/1
N2 - Background and aims: Recent studies underlie the importance of intestinal permeability and chronic inflammation in the pathogenesis of T2DM. Our study compared the concentrations of FABP2 and YKL40 as markers of intestinal permeability and inflammation among normoglycemia, prediabetes and T2DM. Methods: We recruited 122 participants (45 normoglycemic, 26 prediabetes, and 51 T2DM) of whom we measured the fasting serum levels of FABP2 and YKL-40 using ELISA method. Results: The levels of FABP2 were significantly higher in the T2DM group [2.890 (1.880–4.070)] in comparison to both prediabetes [2.025 (1.145–2.343), p = 0.0085] and normoglycemia group [1.72 (1.250–2.645), p = 0.011]. The levels of YKL-40 were also significantly higher in the T2DM group [68.70 (44.61–166.6)] in comparison to both prediabetes [28.85 (20.64–41.53), p < 0.0001] and normoglycemia group [28.64 (19.25–43.87), p < 0.001]. Conclusions: Our study observed that the levels of FABP2 and YKL-40 were highest in the T2DM group supporting the available evidences on the role of intestinal permeability disruption and chronic low-grade inflammation in the pathogenesis of T2DM.
AB - Background and aims: Recent studies underlie the importance of intestinal permeability and chronic inflammation in the pathogenesis of T2DM. Our study compared the concentrations of FABP2 and YKL40 as markers of intestinal permeability and inflammation among normoglycemia, prediabetes and T2DM. Methods: We recruited 122 participants (45 normoglycemic, 26 prediabetes, and 51 T2DM) of whom we measured the fasting serum levels of FABP2 and YKL-40 using ELISA method. Results: The levels of FABP2 were significantly higher in the T2DM group [2.890 (1.880–4.070)] in comparison to both prediabetes [2.025 (1.145–2.343), p = 0.0085] and normoglycemia group [1.72 (1.250–2.645), p = 0.011]. The levels of YKL-40 were also significantly higher in the T2DM group [68.70 (44.61–166.6)] in comparison to both prediabetes [28.85 (20.64–41.53), p < 0.0001] and normoglycemia group [28.64 (19.25–43.87), p < 0.001]. Conclusions: Our study observed that the levels of FABP2 and YKL-40 were highest in the T2DM group supporting the available evidences on the role of intestinal permeability disruption and chronic low-grade inflammation in the pathogenesis of T2DM.
KW - Dysglycemia
KW - FABP2
KW - Inflammation
KW - Intestinal permeability
KW - YKL-40
UR - http://www.scopus.com/inward/record.url?scp=85121832831&partnerID=8YFLogxK
U2 - 10.1016/j.dsx.2021.102366
DO - 10.1016/j.dsx.2021.102366
M3 - Article
AN - SCOPUS:85121832831
SN - 1871-4021
VL - 16
JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
IS - 1
M1 - 102366
ER -